Related Experiment Video

Updated: Oct 26, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Specific NF-kappaB blockade selectively inhibits tumour necrosis factor-alpha-induced COX-2 but not constitutive

C Jobin1, O Morteau, D S Han

  • 1Departments of Medicine, Microbiology, Immunology and the Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, NC 27599, USA.

Immunology
|January 20, 1999
PubMed

Insights

Nuclear factor-kappa B (NF-kappaB) activation is critical for tumor necrosis factor-alpha (TNF-alpha)-induced cyclo-oxygenase-2 (COX-2) gene expression in colon cells. Inhibiting NF-kappaB selectively blocks COX-2 induction, offering specific insights into prostaglandin roles.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Gastroenterology

Background:

  • Cyclo-oxygenase (COX) enzymes regulate the prostaglandin/eicosanoid pathway.
  • COX-1 is constitutively expressed, while COX-2 is inducible by inflammatory signals.
  • NF-kappaB is a key transcription factor involved in inflammatory responses.

Purpose of the Study:

  • To investigate the role of NF-kappaB in TNF-alpha-mediated COX-2 gene expression in colonic epithelial cells.
  • To determine if NF-kappaB activation is essential for COX-2 induction by TNF-alpha.

Main Methods:

  • Utilized an adenoviral vector expressing an NF-kappaB super-repressor (Ad5IkappaB) in HT-29 colonic epithelial cells.
  • Assessed COX-1 and COX-2 mRNA and protein expression following TNF-alpha stimulation.
  • Measured prostaglandin E2 production.

Main Results:

  • TNF-alpha strongly induced COX-2 mRNA, protein, and prostaglandin E2 production in control cells.
  • This induction of COX-2 and prostaglandin E2 was significantly inhibited by Ad5IkappaB, indicating NF-kappaB's crucial role.
  • COX-1 expression remained unchanged by TNF-alpha or NF-kappaB inhibition.

Conclusions:

  • NF-kappaB activation is essential for TNF-alpha-induced COX-2 gene expression in HT-29 cells.
  • Selective inhibition of COX-2 via NF-kappaB blockade may differentiate inducible vs. constitutive prostaglandin functions.
  • This approach offers greater specificity than traditional pharmacological inhibitors for studying intestinal prostaglandin roles.

More Related Videos

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas03:53

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas

Published on: October 10, 2025

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...